ロード中...
Feasibility of a pilot program for COVID‐19 convalescent plasma collection in Wuhan, China
BACKGROUND: A novel coronavirus has caused an international outbreak. Currently, there are no specific therapeutic agents for coronavirus infections. Convalescent plasma (CP) therapy is a potentially effective treatment option. METHODS: Patients who had recovered from COVID‐19 and had been discharge...
保存先:
| 出版年: | Transfusion |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300543/ https://ncbi.nlm.nih.gov/pubmed/32491199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15921 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|